Recipient-Related Clinical Risk Factors for Primary Graft Dysfunction after Lung Transplantation: A Systematic Review and Meta-Analysis

被引:71
作者
Liu, Yao [1 ]
Liu, Yi [1 ]
Su, Lili [1 ]
Jiang, Shu-Juan [1 ]
机构
[1] Shandong Univ, Prov Hosp Affiliated, Dept Resp Med, Jinan 250100, Shandong, Peoples R China
来源
PLOS ONE | 2014年 / 9卷 / 03期
基金
中国国家自然科学基金;
关键词
ISHLT WORKING GROUP; IDIOPATHIC PULMONARY-FIBROSIS; INHALED NITRIC-OXIDE; CARDIOPULMONARY BYPASS; INFLAMMATORY RESPONSE; REPERFUSION INJURY; SURVIVAL; FAILURE; DEFINITION; PRESSURE;
D O I
10.1371/journal.pone.0092773
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Primary graft dysfunction (PGD) is the main cause of early morbidity and mortality after lung transplantation. Previous studies have yielded conflicting results for PGD risk factors. Herein, we carried out a systematic review and meta-analysis of published literature to identify recipient-related clinical risk factors associated with PGD development. Method: A systematic search of electronic databases (PubMed, Embase, Web of Science, Cochrane CENTRAL, and Scopus) for studies published from 1970 to 2013 was performed. Cohort, case-control, or cross-sectional studies that examined recipient-related risk factors of PGD were included. The odds ratios (ORs) or mean differences (MDs) were calculated using random-effects models Result: Thirteen studies involving 10042 recipients met final inclusion criteria. From the pooled analyses, female gender (OR 1.38, 95% CI 1.09 to 1.75), African American (OR 1.82, 95% CI 1.36 to 2.45), idiopathic pulmonary fibrosis (IPF) (OR 1.78, 95% CI 1.49 to 2.13), sarcoidosis (OR 4.25, 95% CI 1.09 to 16.52), primary pulmonary hypertension (PPH) (OR 3.73, 95% CI 2.16 to 6.46), elevated BMI (BMI >= 25 kg/m(2)) (OR 1.83, 95% CI 1.26 to 2.64), and use of cardiopulmonary bypass (CPB) (OR 2.29, 95% CI 1.43 to 3.65) were significantly associated with increased risk of PGD. Age, cystic fibrosis, secondary pulmonary hypertension (SPH), intra-operative inhaled nitric oxide (NO), or lung transplant type (single or bilateral) were not significantly associated with PGD development (all P>0.05). Moreover, a nearly 4 fold increased risk of short-term mortality was observed in patients with PGD (OR 3.95, 95% CI 2.80 to 5.57). Conclusions: Our analysis identified several recipient related risk factors for development of PGD. The identification of higher-risk recipients and further research into the underlying mechanisms may lead to selective therapies aimed at reducing this reperfusion injury.
引用
收藏
页数:12
相关论文
共 56 条
  • [1] INHALED NITRIC-OXIDE IN THE TREATMENT OF POSTOPERATIVE GRAFT DYSFUNCTION AFTER LUNG TRANSPLANTATION
    ADATIA, I
    LILLIHEI, C
    ARNOLD, JH
    THOMPSON, JE
    PALAZZO, R
    FACKLER, JC
    WESSEL, DL
    [J]. ANNALS OF THORACIC SURGERY, 1994, 57 (05) : 1311 - 1318
  • [2] EFFECT OF CARDIOPULMONARY BYPASS ON EARLY GRAFT DYSFUNCTION IN CLINICAL LUNG TRANSPLANTATION
    AEBA, R
    GRIFFITH, BP
    KORMOS, RL
    ARMITAGE, JM
    GASIOR, TA
    FUHRMAN, CR
    YOUSEM, SA
    HARDESTY, RL
    [J]. ANNALS OF THORACIC SURGERY, 1994, 57 (03) : 715 - 722
  • [3] Preoperative Recipient Cytokine Levels Are Associated With Early Lung Allograft Dysfunction
    Allen, Jeremiah G.
    Lee, Maria T.
    Weiss, Eric S.
    Arnaoutakis, George J.
    Shah, Ashish S.
    Detrick, Barbara
    [J]. ANNALS OF THORACIC SURGERY, 2012, 93 (06) : 1843 - 1849
  • [4] Influence of donor-recipient gender mismatch on graft function and survival following lung transplantation
    Alvarez, Antonio
    Moreno, Paula
    Illana, Jennifer
    Espinosa, Dionisio
    Baamonde, Carlos
    Arango, Elisabet
    Javier Algar, Francisco
    Salvatierra, Angel
    [J]. INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2013, 16 (04) : 426 - 435
  • [5] [Anonymous], 2006, NEWCASTLE OTTAWA SCA
  • [6] Medical progress - Lung transplantation
    Arcasoy, SM
    Kotloff, RM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (14) : 1081 - 1091
  • [7] Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part IV:: Recipient-related risk factors and markers
    Barr, ML
    Kawut, SM
    Whelan, TP
    Girgis, R
    Böttcher, H
    Sonett, J
    Vigneswaran, W
    Follette, DM
    Corris, PA
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2005, 24 (10) : 1468 - 1482
  • [8] Leptin resistance protects mice from hyperoxia-induced acute lung injury
    Bellmeyer, Amy
    Martino, Janice M.
    Chandel, Navdeep S.
    Budinger, G. R. Scott
    Dean, David A.
    Mutlu, Gokhan M.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2007, 175 (06) : 587 - 594
  • [9] Outcome of lung transplanted patients with primary graft dysfunction
    Burton, Christopher M.
    Iversen, Martin
    Milman, Nils
    Zemtsovski, Mikhail
    Carlsen, Jorn
    Steinbruchel, Daniel
    Mortensen, Jann
    Andersen, Claus B.
    [J]. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2007, 31 (01) : 75 - 82
  • [10] INFLAMMATORY RESPONSE TO CARDIOPULMONARY BYPASS
    BUTLER, J
    ROCKER, GM
    WESTABY, S
    [J]. ANNALS OF THORACIC SURGERY, 1993, 55 (02) : 552 - 559